[1] RAIMONDO BRUNO . Emerging psychoactive substance use among regular ecstasy users in Australia[J]. Drug and alcohol dependence, 2012, 124 1: Pages 19-25. DOI:
10.1016/j.drugalcdep.2011.11.020[2] PABLO R MOYA. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.[J]. Journal of Pharmacology and Experimental Therapeutics, 2007, 321 3: 1054-1061. DOI:
10.1124/jpet.106.117507[3] MAURER H H. Chemistry, pharmacology, and metabolism of emerging drugs of abuse.[J]. Therapeutic Drug Monitoring, 2010, 32 5: 544-549. DOI:
10.1097/ftd.0b013e3181eea318[4] FOLKER WESTPHAL . Structure elucidation of a new designer benzylpiperazine: 4-Bromo-2,5-dimethoxybenzylpiperazine[J]. Forensic science international, 2009, 187 1: Pages 87-96. DOI:
10.1016/j.forsciint.2009.03.003